BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26850695)

  • 1. Subtle alterations of excitatory transmission are linked to presynaptic changes in the hippocampus of PINK1-deficient mice.
    Feligioni M; Mango D; Piccinin S; Imbriani P; Iannuzzi F; Caruso A; De Angelis F; Blandini F; Mercuri NB; Pisani A; Nisticò R
    Synapse; 2016 Jun; 70(6):223-30. PubMed ID: 26850695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice.
    Kitada T; Pisani A; Porter DR; Yamaguchi H; Tscherter A; Martella G; Bonsi P; Zhang C; Pothos EN; Shen J
    Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11441-6. PubMed ID: 17563363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure to low-dose rotenone precipitates synaptic plasticity alterations in PINK1 heterozygous knockout mice.
    Martella G; Madeo G; Maltese M; Vanni V; Puglisi F; Ferraro E; Schirinzi T; Valente EM; Bonanni L; Shen J; Mandolesi G; Mercuri NB; Bonsi P; Pisani A
    Neurobiol Dis; 2016 Jul; 91():21-36. PubMed ID: 26916954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PINK1 heterozygous mutations induce subtle alterations in dopamine-dependent synaptic plasticity.
    Madeo G; Schirinzi T; Martella G; Latagliata EC; Puglisi F; Shen J; Valente EM; Federici M; Mercuri NB; Puglisi-Allegra S; Bonsi P; Pisani A
    Mov Disord; 2014 Jan; 29(1):41-53. PubMed ID: 24167038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased glutamate transmission onto dorsal striatum spiny projection neurons in Pink1 knockout rats.
    Creed RB; Roberts RC; Farmer CB; McMahon LL; Goldberg MS
    Neurobiol Dis; 2021 Mar; 150():105246. PubMed ID: 33387634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptic dysfunction in Parkinson's disease.
    Picconi B; Piccoli G; Calabresi P
    Adv Exp Med Biol; 2012; 970():553-72. PubMed ID: 22351072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of Non-Apoptotic Role of Caspase-3 in the PINK1 Mouse Model of Parkinson's Disease.
    Imbriani P; Tassone A; Meringolo M; Ponterio G; Madeo G; Pisani A; Bonsi P; Martella G
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased mitochondrial calcium sensitivity and abnormal expression of innate immunity genes precede dopaminergic defects in Pink1-deficient mice.
    Akundi RS; Huang Z; Eason J; Pandya JD; Zhi L; Cass WA; Sullivan PG; Büeler H
    PLoS One; 2011 Jan; 6(1):e16038. PubMed ID: 21249202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative expression proteomics and phosphoproteomics profile of brain from PINK1 knockout mice: insights into mechanisms of familial Parkinson's disease.
    Triplett JC; Zhang Z; Sultana R; Cai J; Klein JB; Büeler H; Butterfield DA
    J Neurochem; 2015 Jun; 133(5):750-65. PubMed ID: 25626353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In search of early neuroradiological biomarkers for Parkinson's Disease: Alterations in resting state functional connectivity and gray matter microarchitecture in PINK1 -/- rats.
    Cai X; Qiao J; Knox T; Iriah S; Kulkarni P; Madularu D; Morrison T; Waszczak B; Hartner JC; Ferris CF
    Brain Res; 2019 Mar; 1706():58-67. PubMed ID: 30389398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of PTEN-induced kinase 1 (Pink1) reduces hippocampal tyrosine hydroxylase and impairs learning and memory.
    Maynard ME; Redell JB; Kobori N; Underwood EL; Fischer TD; Hood KN; LaRoche V; Waxham MN; Moore AN; Dash PK
    Exp Neurol; 2020 Jan; 323():113081. PubMed ID: 31655049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired dopamine release and synaptic plasticity in the striatum of parkin-/- mice.
    Kitada T; Pisani A; Karouani M; Haburcak M; Martella G; Tscherter A; Platania P; Wu B; Pothos EN; Shen J
    J Neurochem; 2009 Jul; 110(2):613-21. PubMed ID: 19457102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pink1-deficiency in mice impairs gait, olfaction and serotonergic innervation of the olfactory bulb.
    Glasl L; Kloos K; Giesert F; Roethig A; Di Benedetto B; Kühn R; Zhang J; Hafen U; Zerle J; Hofmann A; de Angelis MH; Winklhofer KF; Hölter SM; Vogt Weisenhorn DM; Wurst W
    Exp Neurol; 2012 May; 235(1):214-27. PubMed ID: 22265660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hippocampal synaptic failure is an early event in experimental parkinsonism with subtle cognitive deficit.
    Belloso-Iguerategui A; Zamarbide M; Merino-Galan L; Rodríguez-Chinchilla T; Gago B; Santamaria E; Fernández-Irigoyen J; Cotman CW; Prieto GA; Quiroga-Varela A; Rodríguez-Oroz MC
    Brain; 2023 Dec; 146(12):4949-4963. PubMed ID: 37403195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PINK1 Silencing Modifies Dendritic Spine Dynamics of Mouse Hippocampal Neurons.
    Hernández CJ; Báez-Becerra C; Contreras-Zárate MJ; Arboleda H; Arboleda G
    J Mol Neurosci; 2019 Dec; 69(4):570-579. PubMed ID: 31486971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET studies of the striatal dopaminergic system in Parkinson's disease (PD).
    Piccini P; Turjanski N; Brooks DJ
    J Neural Transm Suppl; 1995; 45():123-31. PubMed ID: 8748617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of PINK1 causes age-dependent decrease of dopamine release and mitochondrial dysfunction.
    Zhi L; Qin Q; Muqeem T; Seifert EL; Liu W; Zheng S; Li C; Zhang H
    Neurobiol Aging; 2019 Mar; 75():1-10. PubMed ID: 30504091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of PINK1 mRNA in human and rodent brain and in Parkinson's disease.
    Blackinton JG; Anvret A; Beilina A; Olson L; Cookson MR; Galter D
    Brain Res; 2007 Dec; 1184():10-6. PubMed ID: 17950257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restricted cortical and amygdaloid removal of vesicular glutamate transporter 2 in preadolescent mice impacts dopaminergic activity and neuronal circuitry of higher brain function.
    Wallén-Mackenzie A; Nordenankar K; Fejgin K; Lagerström MC; Emilsson L; Fredriksson R; Wass C; Andersson D; Egecioglu E; Andersson M; Strandberg J; Lindhe O; Schiöth HB; Chergui K; Hanse E; Långström B; Fredriksson A; Svensson L; Roman E; Kullander K
    J Neurosci; 2009 Feb; 29(7):2238-51. PubMed ID: 19228977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation of parkin aggregates and enhanced PINK1 accumulation during the pathogenesis of Parkinson's disease.
    Um JW; Park HJ; Song J; Jeon I; Lee G; Lee PH; Chung KC
    Biochem Biophys Res Commun; 2010 Mar; 393(4):824-8. PubMed ID: 20171192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.